Okusaka T - Search Results

1

Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma.

Finn RS, Ikeda M, Zhu AX, Sung MW, Baron AD, Kudo M, Okusaka T, Kobayashi M, Kumada H, Kaneko S, Pracht M, Mamontov K, Meyer T, Kubota T, Dutcus CE, Saito K, Siegel AB, Dubrovsky L, Mody K, Llovet JM. Finn RS, et al. Among authors: okusaka t. J Clin Oncol. 2020 Sep 10;38(26):2960-2970. doi: 10.1200/JCO.20.00808. Epub 2020 Jul 27. J Clin Oncol. 2020. PMID: 32716739 Free PMC article. Clinical Trial.

2

A phase II study of cisplatin in patients with biliary tract carcinoma.

Okada S, Ishii H, Nose H, Yoshimori M, Okusaka T, Aoki K, Iwasaki M, Furuse J, Yoshino M. Okada S, et al. Among authors: okusaka t. Oncology. 1994 Nov-Dec;51(6):515-7. doi: 10.1159/000227396. Oncology. 1994. PMID: 7970496 Clinical Trial.

3

Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection.

Ishii H, Okada S, Nose H, Okusaka T, Yoshimori M, Takayama T, Kosuge T, Yamasaki S, Sakamoto M, Hirohashi S. Ishii H, et al. Among authors: okusaka t. Cancer. 1996 May 1;77(9):1792-6. doi: 10.1002/(SICI)1097-0142(19960501)77:9<1792::AID-CNCR6>3.0.CO;2-E. Cancer. 1996. PMID: 8646676

4

Clinical response to systemic combined chemotherapy with 5-fluorouracil and cisplatin (FP therapy) in patients with advanced pancreatic cancer.

Okusaka T, Okada S, Ishii H, Nose H, Nakasuka H, Nakayama H, Nagahama H. Okusaka T, et al. Jpn J Clin Oncol. 1996 Aug;26(4):215-20. doi: 10.1093/oxfordjournals.jjco.a023217. Jpn J Clin Oncol. 1996. PMID: 8765178 Clinical Trial.

5

Prognosis of hepatocellular carcinoma patients with extrahepatic metastases.

Okusaka T, Okada S, Ishii H, Nose H, Nagahama H, Nakasuka H, Ikeda K, Yoshimori M. Okusaka T, et al. Hepatogastroenterology. 1997 Jan-Feb;44(13):251-7. Hepatogastroenterology. 1997. PMID: 9058154

6

Predictive factors for tumor response to systemic chemotherapy in patients with hepatocellular carcinoma.

Nagahama H, Okada S, Okusaka T, Ishii H, Ikeda M, Nakasuka H, Yoshimori M. Nagahama H, et al. Among authors: okusaka t. Jpn J Clin Oncol. 1997 Oct;27(5):321-4. doi: 10.1093/jjco/27.5.321. Jpn J Clin Oncol. 1997. PMID: 9390209

7

Hepatocellular carcinoma with gastrointestinal hemorrhage caused by direct tumor invasion to the duodenum.

Okusaka T, Okada S, Ishii H, Nagahama H, Yoshimori M, Yamasaki S, Takayasu K, Kakizoe T, Ochiai A, Shimoda T. Okusaka T, et al. Jpn J Clin Oncol. 1997 Oct;27(5):343-5. doi: 10.1093/jjco/27.5.343. Jpn J Clin Oncol. 1997. PMID: 9390214

8

Transarterial chemotherapy with zinostatin stimalamer for hepatocellular carcinoma.

Okusaka T, Okada S, Ishii H, Ikeda M, Nakasuka H, Nagahama H, Iwata R, Furukawa H, Takayasu K, Nakanishi Y, Sakamoto M, Hirohashi S, Yoshimori M. Okusaka T, et al. Oncology. 1998 Jul-Aug;55(4):276-83. doi: 10.1159/000011863. Oncology. 1998. PMID: 9663415 Clinical Trial.

9

Past exposure to hepatitis B virus as a risk factor for hepatocellular carcinoma in patients with chronic liver disease.

Okada S, Sato T, Okusaka T, Ishii H, Ikeda M, Nakasuka H, Kosakamoto H, Yoshimori M, Wakabayashi K. Okada S, et al. Among authors: okusaka t. Br J Cancer. 1998 Jun;77(11):2028-31. doi: 10.1038/bjc.1998.337. Br J Cancer. 1998. PMID: 9667687 Free PMC article.

10

Undifferentiated carcinoma of the liver with neuroendocrine features: a case report.

Nakasuka H, Okada S, Okusaka T, Ishii H, Ikeda M, Ito R, Kosakamoto H, Yoshimori M, Nakanishi Y, Sakamoto M. Nakasuka H, et al. Among authors: okusaka t. Jpn J Clin Oncol. 1998 Jun;28(6):401-4. doi: 10.1093/jjco/28.6.401. Jpn J Clin Oncol. 1998. PMID: 9730157

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

525 results

Search Page